Nevirapine (Viramune)

Published January 25, 2001; Updated March 2013
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-02-01
Selected Reference
4. Gathe J, Bogner J, Santiago S, et al. Comparison of 48 week efficacy and safety of 400mg QD nevirapine extended release formulation (Viramune XR) versus 200mg BID nevirapine immediate release formulation (Viramune IR) in combination with Truvada in antiretroviral (ARV) naive HIV-1 infected patients (VERxVE). In: Program and abstracts of the XVIII International AIDS Conference; July 18-23, 2010; Vienna. Abstract THLBB202.